E. A. Seftor
Impact in
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Protease and Inhibitor Mechanisms
Papers in
-
- Angiogenesis and VEGF in Cancer 1
- Glycosylation and Glycoproteins Research 1
- Oncology 3
- Cancer Cells and Metastasis 2
- Co-authors
- Mary J.C. Hendrix (8 shared papers)Richard E.B. Seftor (4 shared papers)Mavis S. Fletcher (1 shared paper)Anil K. Sood (1 shared paper)Lynn M.G. Gardner (1 shared paper)Paul M. Heidger (1 shared paper)Dawn A. Kirschmann (1 shared paper)L. A. Liotta (2 shared papers)
- Journals
- Cancer Letters (1 paper)Breast Cancer Research and Treatment (1 paper)Melanoma Research (1 paper)American Journal Of Pathology (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United States
In The Last Decade
E. A. Seftor
8 papers receiving 642 citations
Peers
Comparison fields: 5 of 68
- Immunology and Allergy 85
- Cancer Research 168
- Cell Biology 125
- Molecular Biology 440
- Oncology 142
Countries citing papers authored by E. A. Seftor
This map shows the geographic impact of E. A. Seftor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. A. Seftor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. A. Seftor more than expected).
Fields of papers citing papers by E. A. Seftor
This network shows the impact of papers produced by E. A. Seftor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. A. Seftor. The network helps show where E. A. Seftor may publish in the future.
Co-authors
The 25 scholars most cited alongside E. A. Seftor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 218 | |
| 2 | 1992 | 152 | |
| 3 | Down-regulation of HP1Hsalpha expression is associated with the metastatic phenotype in breast cancer. | 2000 | 106 |
| 4 | 1999 | 96 | |
| 5 | 1991 | 33 | |
| 6 | Selection of invasive and metastatic subpopulations from a heterogeneous human melanoma cell line. | 1990 | 22 |
| 7 | Retinoic acid inhibits human melanoma tumor cell invasion. | 1990 | 14 |
| 8 | 1989 | 6 |
About E. A. Seftor
E. A. Seftor is a scholar working on Molecular Biology, Oncology, Cell Biology, Immunology and Allergy and Cancer Research, having authored 8 papers that have together received 647 indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (2 papers), Cancer Cells and Metastasis (2 papers), Skin and Cellular Biology Research (2 papers), Angiogenesis and VEGF in Cancer (1 paper), Glycosylation and Glycoproteins Research (1 paper), Cancer Genomics and Diagnostics (1 paper), Click Chemistry and Applications (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Immunology and Allergy (85 citations), Cancer Research (168 citations), Cell Biology (125 citations), Molecular Biology (440 citations) and Oncology (142 citations). E. A. Seftor has collaborated with scholars based in United States. Frequent co-authors include Mary J.C. Hendrix, Richard E.B. Seftor, Mavis S. Fletcher, Anil K. Sood, Lynn M.G. Gardner, Paul M. Heidger, Dawn A. Kirschmann, L. A. Liotta, William G. Stetler‐Stevenson and Danny R. Welch. Their work appears in journals such as Cancer Letters, Breast Cancer Research and Treatment, Melanoma Research, American Journal Of Pathology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.